Comparison of dopamine D2 receptor occupancy profiles between risperidone ism versus oral risperidone and monthly paliperidone palmitate based on population pharmacokinetic modelling and simulations
{{output}}
Background: Risperidone-ISM® does not require loading dose or oral supplementation. Dopamine D2 Receptor Occupancy (D2RO) profiles between Risperidone-ISM® versus oral risperidone (OR) and monthly-paliperidone palmitate (PP1M) ... ...
